tiprankstipranks
Trending News
More News >
Venture Life Group PLC (GB:VLG)
LSE:VLG

Venture Life (VLG) Price & Analysis

Compare
4 Followers

VLG Stock Chart & Stats

65.50p
-1.00p(-2.59%)
At close: 4:00 PM EST
65.50p
-1.00p(-2.59%)

Bulls Say, Bears Say

Bulls Say
Improving Free Cash FlowImproving free cash flow despite weaker net income shows stronger cash conversion and operational resilience. Sustained FCF enhances the firm’s ability to fund R&D, support distribution agreements, service liabilities or execute buybacks without relying heavily on external financing.
Healthy Balance Sheet BaseA stable equity base and manageable leverage provide financial flexibility to invest in product development, regulatory work and go-to-market expansion. This balance-sheet strength helps the company withstand revenue volatility and supports strategic initiatives over the medium term.
Diversified Revenue Channels & PartnershipsA diversified model—branded and private label sales, licensing, third-party distributors and retailer partnerships—reduces single-channel dependency, broadens market reach and supports scaling new products, improving resilience to shifts in any single distribution route.
Bears Say
Declining Revenue And Negative MarginsRevenue decline with gross and net margins turning negative in 2024 signals structural demand or pricing pressure and erosion of core economics. Persistent negative margins reduce reinvestment capacity and may require operational restructuring that could impair long-term growth prospects.
Margin Compression At Operating LevelDecreasing EBIT and EBITDA margins indicate worsening operating efficiency or rising costs. Sustained margin compression reduces cash available for innovation, marketing and distribution expansion, weakening competitiveness if the company cannot restore structural profitability.
Rising Liabilities RiskA gradual increase in liabilities elevates leverage and refinancing risk even with a healthy equity ratio. If cash generation falters, higher liabilities can limit strategic flexibility, force costlier financing or necessitate asset sales, constraining long-term investment capacity.

Venture Life News

VLG FAQ

What was Venture Life Group PLC’s price range in the past 12 months?
Venture Life Group PLC lowest share price was 32.00p and its highest was 68.00p in the past 12 months.
    What is Venture Life Group PLC’s market cap?
    Venture Life Group PLC’s market cap is £82.75M.
      When is Venture Life Group PLC’s upcoming earnings report date?
      Venture Life Group PLC’s upcoming earnings report date is Mar 31, 2026 which is in 58 days.
        How were Venture Life Group PLC’s earnings last quarter?
        Currently, no data Available
        Is Venture Life Group PLC overvalued?
        According to Wall Street analysts Venture Life Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Venture Life Group PLC pay dividends?
          Venture Life Group PLC pays a Annually dividend of 0.04p which represents an annual dividend yield of N/A. See more information on Venture Life Group PLC dividends here
            What is Venture Life Group PLC’s EPS estimate?
            Venture Life Group PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Venture Life Group PLC have?
            Venture Life Group PLC has 124,639,340 shares outstanding.
              What happened to Venture Life Group PLC’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Venture Life Group PLC?
              Currently, no hedge funds are holding shares in GB:VLG
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Venture Life Group PLC

                Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

                Venture Life (VLG) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Allergy Therapeutics
                N4 Pharma
                Provexis
                Shield Therapeutics
                Haleon PLC

                Options Prices

                Currently, No data available
                ---
                Popular Stocks